In this issue:
– Teplizumab in relatives at risk for type 1 diabetes
– Outcomes in offspring after use of metformin for gestational diabetes
– Bariatric surgery vs intensive medical therapy for diabetes
– Impact of CGM on glycaemic control in patients with type 2 diabetes treated with basal insulin
– Primary care-led weight management for remission of type 2 diabetes
– COVID-19 in people with diabetes
– SGLT-2 inhibitors and GLP-1 receptor agonists for type 2 diabetes
– Effects of lifestyle intervention vs metformin on diabetes development in at-risk patients
– Global trends in diabetes since 1980
– Advanced hybrid closed loop therapy in adults with type 1 diabetes
– Novel subgroups of adult-onset diabetes
– Time in range is a useful outcome measure for diabetes trials
– Impact of low-fat diets vs other diets on long-term weight change
Expert contributor
Professor Krebs is an Endocrinologist with a particular interest in obesity and diabetes. He trained in Endocrinology at Wellington Hospital in New Zealand and then did his doctorate with the Medical Research Council – Human Nutrition Research unit in Cambridge England. His thesis was on the impact of dietary factors on obesity and insulin resistance. […]
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.